Formosa Laboratories, Inc. Approves Dividend Distribution for Full Year Ended December 31, 2023
March 12, 2024 at 08:14 am
Share
The Board of Directors of Formosa Laboratories, Inc. approved dividend distribution for full year ended December 31, 2023. Appropriations of earnings in cash dividends to shareholders is TWD 2.00 per share. Total amount of cash distributed to shareholders TWD 240,511,926.
Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.
FORMOSA LABORATORIES, INC. 
